<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM873478"><item key="CELL TYPE">human bone marrow CD38-</item></item></item><item><item key="GSM873478"><item key="CELL TYPE">human bone marrow CD38-</item></item></item><item><item key="GSM873478"><item key="CELL TYPE">human bone marrow CD38-</item></item></item><item><item key="GSM87348"><item key="CELL TYPE">human bone marrow CD62Lhi</item></item></item><item><item key="GSM87348"><item key="CELL TYPE">human bone marrow CD62Lhi</item></item></item><item><item key="GSM87348"><item key="CELL TYPE">human bone marrow CD62Lhi</item></item></item><item><item key="GSM873484"><item key="CELL TYPE">human bone marrow CD10+</item></item></item><item><item key="GSM873484"><item key="CELL TYPE">human bone marrow CD10+</item></item></item><item><item key="GSM873484"><item key="CELL TYPE">human bone marrow CD10+</item></item></item></item><item key="id">4413</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel...</item><item key="geo_gse_id">E-GEOD-35685</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">9</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>genome</item><item>intermediate</item><item>l-selectin</item><item>selectin</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">lymphoid-priming-in-human-bone-marrow-begins-prior</item><item key="geo_id_plat">E-GEOD-35685_A-AFFY-44</item><item key="name">Lymphoid Priming in Human Bone Marrow Begins Prior to CD10 Expression with Up-Regulation of L-selectin</item><item key="created">Sep.19, 2014</item><item key="summary">Studies of adult human hematopoiesis have until now relied on the expression of CD10 to define lymphoid commitment. We report a novel lymphoid-primed population in human bone marrow that is generated from hematopoietic stem cells (HSC) prior to the onset of CD10 expression and B cell commitment, and is identified by high levels of the homing molecule L-selectin (CD62L). CD10-CD62Lhi progenitors have full lymphoid (B/T/NK) potential, and show reduced myeloid and absent erythroid potential. Genome-wide gene expression analysis demonstrates that the CD10-CD62Lhi population represents an intermediate stage of differentiation between CD34+CD38- HSC and CD34+lin-CD10+ progenitors marked by down-regulation of TAL1 and MPL, upregulation of E2A, CD3E and IL2RG expression, and absent B cell commitment or RAG1/2 expression. Immature CD34+CD1a- thymocytes are also CD62Lhi and L-selectin ligands are expressed at the cortico-medullary junction, suggesting a possible role for L-selectin in human thymic homing. These studies identify the earliest stage of lymphoid priming in human bone marrow. Freshly harvested human bone marrow was ficoll purified, enriched for CD34+, and then FACS sorted. It was then sorted into 3 samples CD34+CD38-, CD34+ CD10- CD62L++, and CD34+ CD10+, with 3 independent biological replicates</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-35685</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-35685/samples/</item></data></biogps>
